Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

BACKGROUND: FVC outcomes in clinical trials on idiopathic pulmonary fibrosis (IPF) can be substantially influenced by the analytic methodology and the handling of missing data. We conducted a series of sensitivity analyses to assess the robustness of the statistical finding and the stability of the...

詳細記述

保存先:
書誌詳細
出版年:Chest
主要な著者: Lederer, David J., Bradford, Williamson Z., Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Glasscock, Kenneth F., Kardatzke, David, King, Talmadge E., Lancaster, Lisa H., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Swigris, Jeffrey J., Noble, Paul W.
フォーマット: Artigo
言語:Inglês
出版事項: American College of Chest Physicians 2015
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493875/
https://ncbi.nlm.nih.gov/pubmed/25856121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-2817
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料